The project objective was to characterize stabilization of human recombinant Factor VIII (FVIII) with two surfactants, Pluronic® F-68 (F68) and Polysorbate 80 (PS80). Factor VIII is an essential blood clotting protein manufactured for treatment of Hemophilia A. Factor VIII has multiple hydrophobic regions requiring the use of amphiphilic molecules, such...